Jean M. Lablanche

Risk Factors for Stent Thrombosis After Implantation of Sirolimus-Eluting Stents in Diabetic and Nondiabetic Patients

J Machecourt, Nicolas Danchin, Jean M. Lablanche et al. · Journal of the American College of Cardiology · 2007 · 207 citations

Stent Thrombosis, Diabetes Management, Cardiovascular Disease +10

Percutaneous coronary rotational angioplasty in humans: Preliminary report

Jean L. Fourrier, Michel E. Bertrand, David C. Auth et al. · Journal of the American College of Cardiology · 1989 · 108 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Preliminary Report +6

Percutaneous transluminal coronary rotary ablation with Rotablator (European experience)

Michel E. Bertrand, Jean M. Lablanche, Fabrice Leroy et al. · The American Journal of Cardiology · 1992 · 94 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Minimally Invasive Procedure +7

Detrimental effect of propranolol in patients with coronary arterial spasm countered by combination with diltiazem

Pierre Y. Tilmant, Jean M. Lablanche, F. Thieuleux et al. · The American Journal of Cardiology · 1983 · 82 citations

Thrombosis, Cardiovascular Disease, Atherosclerosis +10

Coronary sinus blood flow at rest and during isometric exercise in patients with aortic valve disease

Michel E. Bertrand, Jean M. Lablanche, Pierre Y. Tilmant et al. · The American Journal of Cardiology · 1981 · 70 citations

Physical Activity, Kinesiology, Cardiovascular Disease +15